Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA as the measure of average blood glucose levels for the 3 months preceding the HbA test date. The use of this measure highlights the long-establi...

Full description

Bibliographic Details

Published in:	The lancet. Diabetes & endocrinology Vol. 11; no. 1; p. 42
Main Authors:	Battelino, Tadej, Alexander, Charles M, Amiel, Stephanie A, Arreaza-Rubin, Guillermo, Beck, Roy W, Bergenstal, Richard M, Buckingham, Bruce A, Carroll, James, Ceriello, Antonio, Chow, Elaine, Choudhary, Pratik, Close, Kelly, Danne, Thomas, Dutta, Sanjoy, Gabbay, Robert, Garg, Satish, Heverly, Julie, Hirsch, Irl B, Kader, Tina, Kenney, Julia, Kovatchev, Boris, Laffel, Lori, Maahs, David, Mathieu, Chantal, Mauricio, Dídac, Nimri, Revital, Nishimura, Rimei, Scharf, Mauro, Del Prato, Stefano, Renard, Eric, Rosenstock, Julio, Saboo, Banshi, Ueki, Kohjiro, Umpierrez, Guillermo E, Weinzimer, Stuart A, Phillip, Moshe
Format:	Journal Article
Language:	English
Published:	England 01.01.2023
Subjects:	Adolescent Blood Glucose - analysis Blood Glucose Self-Monitoring Child Clinical Trials as Topic Diabetes Mellitus, Type 1 - drug therapy Humans Hyperglycemia - therapy Hypoglycemia - prevention & control Prospective Studies
ISSN:	2213-8595, 2213-8595
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!